Konventionelle nuklearmedizinische Diagnostik in der Nachsorge nach Herztransplantation

Cornelia Puskäs; S. Kerber; M. Weyand; O. Schober

doi:10.1055/s-0038-1629772

Nuklearmedizin - NuclearMedicine, Table of Contents

Nuklearmedizin 1996; 35(01): 31-37
DOI: 10.1055/s-0038-1629772

Original Article

Schattauer GmbH

Konventionelle nuklearmedizinische Diagnostik in der Nachsorge nach Herztransplantation

Capability of Nuclear Medicine Procedures in the Follow-up of Heart Transplant Recipients

Authors

Cornelia Puskäs

¹Aus der Klinik und Poliklinik für Nuklearmedizin (Dir.: Prof. Dr. Dr. O. Schober) Westfälische Wilhelms-Universität Münster, Deutschland
S. Kerber

²Aus der Medizinischen Klinik und Poliklinik -Kardiologie/Angiologie – (Dir.: Prof. Dr. G. Breithardt) Westfälische Wilhelms-Universität Münster, Deutschland
M. Weyand

³Aus der Klinik und Poliklinik für Thorax-, Herz- und Gefäßchirurgie (Dir.: Prof. Dr. H. H. Scheid) Westfälische Wilhelms-Universität Münster, Deutschland
O. Schober

¹Aus der Klinik und Poliklinik für Nuklearmedizin (Dir.: Prof. Dr. Dr. O. Schober) Westfälische Wilhelms-Universität Münster, Deutschland

Abstract

Zusammenfassung

Die 1-Jahres-Überlebensrate nach Herztransplantation liegt unter der Erhaltungstherapie mit Immunsuppressiva aktuell über 80%. Im ersten Jahr nach dem Eingriff stellen Rejektionskrisen und akute Infektionen die Haupttodesursachen dar. Danach ist die Lebenserwartung der Transplantatempfänger im wesentlichen durch eine für das transplantierte Herz charakteristische progrediente Angiopathie, die Graft-Arteriosklerose, limitiert. Die Graft-Arteriosklerose zeichnet sich aus durch eine fortschreitende Intimaverdickung in allen koronaren Gefäßsegmenten.

In der vorliegenden Übersicht werden die nuklearmedizinischen Verfahren vorgestellt, die bei der Diagnostik von Rejektion und vaskulären Komplikationen einen gewissen klinischen Stellenwert erlangt haben. Es sind dies die Immunszintigraphie mit ¹¹¹In-markierten monoklonalen Antikörpern gegen Myosin, die Radionuklidventrikulographie und die Perfusionsszintigraphie des Myokards. Die allmählich fortschreitende sympathische Reinnervation des Herzmuskels wird durch die Anreicherung von [¹²³l]-meta-lod-Benzylguanidin angezeigt.

Summary

Actually more than 80% of heart recipients survive the first postoperative year. Early death is mainly caused by rejection and acute infection. After the first year progressive graft atherosclerosis has the greatest impact on prognosis.

The review presents scintigraphic methods that have reached clinical Impact in the diagnosis of rejection and vascular complications. Immuno-scintigraphy with ¹¹¹1n-labelled monoclonal antibodies against myosin proved to be of importance in the diagnosis of rejection especially in long-term follow-up. Perfusion scintigraphy reveals vital and ischemic myocardium. In heart transplant recipients radionuclide ventriculography has been widely replaced by echocardiography. Up to now, the evaluation of increasing nerval integration with ¹²³I-MIBG has not reached clinical impact.

Schlüsselwörter

Herztransplantation - Nachsorge - Myokardszintigraphie - Radionuklidven-trikulographie

Keywords

Heart transplantation - follow-up - myocardial scintigraphy - radionuclide ventriculography

Full Text

References

Literatur
1 Ambrosi P, Habib G, Kreitman B. et al. Thallium perfusion and myocardial hypertrophy in transplanted heart recipients with normal or near-normal coronary angiograms. Eur Heart J 1994; 15: 1119-23.
2 Anderson TJ, Meredith IT, Uehata A. et al. Functional significance of intimai thickening as detected by intravascular ultrasound early and late after cardiac transplantation. Circulation 1993; 88: 1093-100.
3 Ballester M, Obrador D, Carrió I. et al. Indium-lll-monoclonal antimyosin antibody studies after the first year of heart transplantation. Circulation 1990; 82: 2100-8.
4 Ballester M, Obrador D, Carrió I. et al. Early postoperative reduction of monoclonal antimyosin antibody uptake is associated with absent rejection related complications after heart transplantation. Circulation 1992; 85: 61-8.
5 Billingham ME. Histopathology of graft coronary disease. J Heart Lung Transplant 1992; 11: S38-S44.
6 Carrió I, Berná L, Ballester M. et al. Indium-Ill antimyosin scintigraphy to assess myocardial damage in patients with suspected myocarditis and cardiac rejection. J Nucl Med 1988; 29: 1893-900.
7 Carriö I, Estorch M, Bernä L. et al. Assessment of anthracycline-induced myocardial damage by quantitative indium-Ill myosin-specific monoclonal antibody studies. Eur J Nucl Med 1991; 18: 806-12.
8 Ciliberto GR, Mangiovacchi M, Banfi F. et al. Coronary artery disease after heart transplantation: non-invasive evaluation with exercise thallium scintigraphy. Eur Heart J 1993; 14: 226-9.
9 Dae MW, De Marco T, Botvinick EH. MIBG uptake at one year post cardiac transplant -evidence for partial reinnervation in man. J Nucl Med 1992; 33: 896.
10 Deiwick M, Hamann PA, Weyand M. et al. Heterotope Herztransplantation – eine Alternative in der Therapie der terminalen Herzinsuffizienz. Tx Med 1994; 6: 262-9.
11 Desruennes M, Solis E, Cabrol A. et al. Doppler echocardiography: an excellent noninvasive method for the detection of acute allograft rejection. Transplant Proc 1989; 21: 3634-8.
12 Escobar A, Ventura HO, Stapleton DD. et al. Cardiac allograft vasculopathy assessed by intravascular ultrasonography and non-immunologic risk factors. Am J Cardiol 1994; 74: 1042-6.
13 Fishbein MC, Bell G, Lones MA. et al. Grade 2 cellular heart rejection: does it exist?. J Heart Lung Transplant 1994; 13: 1051-7.
14 Follansbee WP, Kiernan JM, Curtiss EI. et al. Changes in left ventricular systolic function that accompany rejection of the transplanted heart: a serial radionuclide assessment of fifty-three consecutive cases. Am Heart J 1991; 121: 548-56.
15 Gao SZ, Alderman EL, Schroeder JS. et al. Progressive coronary luminal narrowing after cardiac transplantation. Circulation 1990; 82 suppl IV 269-75.
16 Grover-McKay M. How can positron emission tomography help evaluate patients before and after heart transplantation. J Nucl Med 1993; 34: 834-8.
17 Gürtner Ch, Klepzig H, Lelbach S. et al. Sympathische Reinnervation nach Herztransplantation – Doppelnuklidstudie mit I-123-MIBG und Tl-201. Nukl Med 1994; 33: 106-12.
18 Hartmann A, Maul FD, Huth A. et al. Serial evaluation of left ventricular function by radionuclide ventriculography at rest and during exercise after orthotopic heart transplantation. Eur J Nucl Med 1993; 20: 146-50.
19 Haverich A, Kemnitz J, Fieguth HG. et al. Non-invasive parameters for detection of cardiac allograft rejection. Clin Transplant 1987; 1: 151-8.
20 Iturralde M, Novitzky D, Cooper DKC. et al. The role of nuclear cardiology procedures in the evaluation of cardiac function following heart transplantation. Sem Nucl Med 1988; 18: 221-40.
21 Johnson DE, Alderman EL, Schroeder JS. et al. Transplant coronary artery disease: histopathologic correlations with angiographic morphology. J Am Coll Cardiol 1991; 17: 449-57.
22 Kerber S, Rahmel A, Karbenn U. et al. Allograft- Vaskulopathie in der Frühphase nach orthotoper Herztransplantation: angiographische, intravaskulär-sonographische und funktionelle In-vivo-Befunde. Z Kardiol 1994; 83: 215-24.
23 Klauss V, Rieber J, Überfuhr P. et al. Variabilität der Transplantatvaskulopathie. Eine Untersuchung mit intravaskulärem Ultraschall (IVUS). Z Kardiol 1995; 84: 121-9.
24 Latre JM, Arizön JM, Jimenez-Heffernan A. et al. Noninvasive radioisotopic diagnosis of acute heart rejection. J Heart Lung Transplant 1992; 11: 453-7.
25 Latre JM, Anguita M, Arizön JM. et al. Noninvasive follow-up of episodes of significant acute heart rejection by radioisotopic methods (letter). J Heart Lung Transplant 1993; 12 (Suppl. 05) 882-3.
26 Lee KL, Wallis JW, Miller TR. et al. The clinical utility of radionuclide ventriculography in cardiac transplantation. J Nucl Med 1990; 31: 1933-9.
27 Mason JW, Strefling A. Small vessel disease of the heart resulting in myocardial necrosis and death despite angiographically normal coronary arteries. Am J Cardiol 1979; 44: 171-6.
28 McDonald K, Rector TS, Braulin EA. et al. Association of coronary artery disease in cardiac transplant recipients with cytomegalovirus infection. Am J Cardiol 1989; 64: 359-62.
29 McGiffin DC, Karp RB, Logic JR. et al. Results of radionuclide assessment of cardiac function following transplantation of the heart. Ann Thorac Surg 1984; 37: 382-6.
30 McKillop JH, Goris ML. Thallium-201 myocardial imaging in patients with previous cardiac transplantation. Clin Radiol 1981; 32: 447-9.
31 Nisco SJ, Reitz BA. Developments in cardiac transplantation. Current opinion in cardiology 1994; 9: 237-46.
32 O’Neill BJ, Pflugfelder PW, Singh NR. et al. Frequency of angiographic detection and quantitative assessment of coronary arterial disease one and three years after cardiac transplantation. Am J Cardiol 1989; 63: 1221-6.
33 Olivari MT, Kubo SH, Braunlin EA. et al. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplantation. Circulation 1990; 82 suppl IV IV276-IV280.
34 Pflugfelder PW, Boughner DR, Rudas L. et al. Enhanced detection of cardiac allograft arterial disease with intracoronary ultrasonographic imaging. Am Heart J 1993; 125: 1583-91.
35 Pinto FJ, St. Goar FG Gao SZ. et al. Immediate and one-year safety of intracoronary ultrasonic imaging. Evaluation with serial quantitative angiography. Circulation 1993; 88: 1709-14.
36 Pinto FJ, Chenzbraun A, Botas J. et al. Feasibility of serial intracoronary ultrasound imaging for assessment of progression of intimal proliferation in cardiac transplant recipients. Circulation 1994; 90: 2348-55.
37 Puskäs C, Kosch M, Jonas M. et al. Myokardszintigraphie mit Tl-201: hochsensitiver Nachweis der Transplantatvaskulopathie?. Nucl Med 1995; 34: A129. (abs)
38 Rahmel A, Deng M, Kerber S. et al. Herztransplantations-Nachsorge: das Miinstera-ner Modell. Tx Med 1994; 6: 270-6.
39 Rickenbacher PR, Pinto FJ, Chenzbraun A. et al. Incidence and severity of transplant coronary artery disease early and up to 15 years after transplantation as detected by intravascular ultrasound. J Am Coll Cardiol 1995; 25: 171-7.
40 Rodney RA, Johnson LL. Myocardial perfusion scintigraphy to assess heart transplant vasculopathy. J Heart Lung Transplant 1992; 11: S74-S78.
41 Rodney RA, Johnson LL, Blood DK. et al. Myocardial perfusion scintigraphy in heart transplant recipients with and without allograft atherosclerosis: a comparison of thallium-201 and technetium-99m sestamibi. J Heart Lung Transplant 1994; 13: 173-80.
42 Schuetz A, Kemkes BM, Breuer M. et al. Kinetics and dynamics of acute rejection after heterotopic heart transplantation. J Heart Lung Transplant 1992; 11: 289-300.
43 Smart FW, Ballantyne CM, Cocanougher B. et al. Insensitivity of noninvasive tests to detect coronary artery vasculopathy after heart transplant. Am J Cardiol 1991; 67: 243-7.
44 St. Goar FG, Fausto JP, Alderman EL. et al. Intracoronary ultrasound in cardiac transplant recipients. Circulation 1992; 85: 979-87.
45 Valantine HA, Fowler MB, Hunt SA. et al. Changes in Doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. Circulation 1987; 76 suppl V V86-V92.
46 Valette H, Bourguignon MH, Merlet P. et al. Ventricular function during the acute rejection of heterotopic transplanted heart: gated blood-pool studies. Eur J Nucl Med 1991; 18: 879-84.
47 Von Scheidt W, Reichart B, Erdmann E. Myokardfunktion, arterielle Hypertonie und Koronarangiopathie nach Herztransplantation. Med Klin 1995; 90: 90-5.